tofacitinib
Showing 51 - 67 of 67
Rheumatoid Arthritis Trial in Aventura (tofacitinib)
Completed
- Rheumatoid Arthritis
- tofacitinib
-
Aventura, FloridaAARDS Research, Inc.
Jul 2, 2019
Arthritis, Rheumatoid Trial in Worldwide (tofacitinib, adalimumab, etanercept)
Completed
- Arthritis, Rheumatoid
- tofacitinib
- +2 more
-
Birmingham, Alabama
- +344 more
Jul 21, 2021
Alopecia Areata Trial in New York (Tofacitinib)
Completed
- Alopecia Areata
- Tofacitinib
-
New York, New YorkColumbia University Medical Center
Apr 16, 2019
Arthritis, Psoriatic Trial in Worldwide (Tofacitinib, Methotrexate, Placebo Methotrexate)
Completed
- Arthritis, Psoriatic
- Tofacitinib
- +2 more
-
Birmingham, Alabama
- +152 more
May 6, 2020
Systemic Lupus Erythematosus Trial run by the NIAMS (Tofacitinib, Placebo)
Completed
- Systemic Lupus Erythematosus
- Tofacitinib
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 8, 2018
Extranodal NK/T-cell Lymphoma Trial in Chengdu (tofacitinib, chidamide)
Unknown status
- Extranodal NK/T-cell Lymphoma
- tofacitinib
- chidamide
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jul 24, 2018
Rheumatoid Arthritis Trial in Worldwide (PF-06650833, Placebo, Tofacitinib)
Alopecia Areata, Alopecia Totalis, Alopecia Universalis Trial in Stanford (Tofacitinib)
Completed
- Alopecia Areata
- +2 more
- Tofacitinib
-
Stanford, CaliforniaStanford University
Oct 4, 2017
Rheumatoid Arthritis Trial in United States (Tofacitinib, Placebo)
Completed
- Rheumatoid Arthritis
- Tofacitinib
- Placebo
-
Jonesboro, Arkansas
- +35 more
Mar 13, 2018
Psoriatic Arthritis Trial in Worldwide (Tofacitinib, Placebo)
Completed
- Psoriatic Arthritis
- Tofacitinib
- Placebo
-
Birmingham, Alabama
- +124 more
Sep 8, 2017
Data From CP-690,550-treated Kidney Transplant Recipients
Completed
- Kidney Transplantation
- Tofacitinib
-
Los Angeles, California
- +42 more
Sep 25, 2013
Psoriasis, Immunomodulation Trial in Little Rock (tofacitinib)
Completed
- Psoriasis
- Immunomodulation
- tofacitinib
-
Little Rock, ArkansasPfizer Investigational Site
Jan 16, 2013